Clin2
NCT06506630Possibly a fitRecruiting

Coenzyme Q10 for metabolic syndrome risk

Metabolic SyndromeCardiovascular Diseases

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests whether taking Coenzyme Q10, a natural supplement, can improve heart health markers in people who have or are at high risk for metabolic syndrome. Metabolic syndrome is a group of conditions like high blood sugar, high blood pressure, and belly fat that raise your risk for heart disease and diabetes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
30 years to 90 years
Study type
Interventional

Who can take part

  • Be between 30 and 90 years old
  • Have metabolic syndrome or be at high risk (at least 2 conditions like belly fat, high blood sugar, high blood pressure, or unhealthy cholesterol)
  • Not have taken aspirin, fish oil, or similar supplements in the last 6 months
  • Not be pregnant, nursing, or have certain health problems like bleeding disorders or stomach ulcers
  • Agree to participate and sign a consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06908473Enrolling by invitation· Phase 3
Tongmai Jiangtang capsule for heart risks in metabolic syndrome

This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.

Guangzhou, Guangdong
NCT06647108Not yet recruiting
Food supplement for metabolic syndrome

This study tests a dietary supplement designed for people with metabolic syndrome. It aims to see if the supplement can help improve key markers of metabolic health, like blood sugar and cholesterol levels.

Bologna, Bologna
NCT07505277Recruiting
Testing special foods for people at risk of metabolic syndrome

This trial tests whether foods with antioxidants, prebiotic fibers, and oat beta-glucans can help people who are at risk for metabolic syndrome. It looks at measures like waist size, blood sugar, blood pressure, and cholesterol to see if these foods improve health markers.

Bolzano, Bolzano
NCT06158152Recruiting
AM3 supplement for metabolic syndrome pilot study

This study tests an oral supplement called AM3 in people with metabolic syndrome. It looks at whether the supplement can help improve sugar and fat levels in the blood.

Madrid
NCT07748130Not yet recruiting
Coenzyme Q10 for liver fat in mitochondrial diabetes

This study tests whether coenzyme Q10, a natural supplement, can reduce fat in the liver for people with mitochondrial diabetes, a rare form of diabetes caused by a specific gene change. If you have this condition, the study aims to see if the supplement improves liver health.

Putian, Fujian
NCT05984745Recruiting· Phase 2
CoQ10 for fatty liver linked to metabolic issues

This study tests if CoQ10 (a natural supplement) can improve liver health in people with metabolic dysfunction-associated fatty liver disease (MAFLD). It may help if you have a fatty liver and related metabolic issues like high blood pressure or diabetes.

Cairo

Hear when a new Metabolic Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.